Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Leukemia × Thiotepa × Clear all

Phase

Status

Completed 22 Terminated 6 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Central Nervous System Neoplasms 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Sarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Mycosis Fungoides 1 Medulloblastoma 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1

Interventions

Rituximab 9 Cyclophosphamide 9 fludarabine phosphate 8 Cytarabine 8 Peripheral Blood Stem Cell Transplantation 7 Filgrastim 6 fludarabine 5 Methotrexate 5 Cyclosporine 5 Busulfan 5 Idarubicin 4 Granulocyte Colony-Stimulating Factor 4 Bendamustine Hydrochloride 4 venetoclax 3 duvelisib 3 Whole-Body Irradiation 3 Tacrolimus 3 Sirolimus 3 Radiotherapy 3 Mycophenolic Acid 3 Antilymphocyte Serum 3 Mitoxantrone 2 Melphalan 2 Lenalidomide 2 Interferon-alpha 2 Drug Therapy 2 Amifostine 2 urelumab 1 sargramostim 1 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00972101 2012-10-11

Infusion of Expanded Cord Blood T Cells

M.D. Anderson Cancer Center

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡